Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Net revenues	$ 3,200,000	$ 2,962,000
Cost of revenues	1,708,000	1,704,000
Gross profit	1,492,000	1,258,000
Expenses:
Sales and marketing	444,000	341,000
Research and development	609,000	563,000
General and administrative	1,648,000	1,260,000
Total operating expenses	2,701,000	2,164,000
Loss from operations	(1,209,000)	(906,000)
Interest expense	(3,531,000)	(1,132,000)
Other income (expenses)	10,000	(9,000)
Loss on equity method investments	(13,000)
Total other expenses	(3,534,000)	(1,141,000)
Net loss	(4,743,000)	(2,047,000)
Loss attributable to noncontrolling interests	(141,000)	(176,000)
Net loss attributable to common stockholders	(4,602,000)	(1,871,000)
Net loss	(4,743,000)	(2,047,000)
Other comprehensive loss:
Foreign currency translation adjustments gain (loss)	38,000	(4,000)
Comprehensive loss	(4,705,000)	(2,051,000)
Comprehensive loss attributable to noncontrolling interests	(141,000)	(176,000)
Comprehensive loss attributable to common stockholders	$ (4,564,000)	$ (1,875,000)
Per share data:
Basic and diluted net loss per common share (in dollars per share)	$ (1.11)	$ (0.76)
Weighted average common shares outstanding – basic and diluted (in shares)	4,135,644	2,461,415